
Nick Damiano
First YC medtech founder and only 2x YC medtech founder; Co-founder & CEO @ Andromeda Surgical S23; Founder & CEO @ Zenflow W15 - treated > 300 patients so far, Class 3 FDA approval, raised > $100M; Co-founder & CTO @ Avail MedSystems (f.k.a. Nurep, acq. by Mendaera) - launched in 1000 hospitals, raised $120M; Venture Partner @ Pioneer Fund; Stanford Biodesign Innovation Fellow & Stanford MS/BS; Generalist/SW engineer; Dad to two daughters; Semicolon enthusiast;
We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.